Form 8-K - Current report:
SEC Accession No. 0001558370-23-012601
Filing Date
2023-08-01
Accepted
2023-07-31 18:23:11
Documents
13
Period of Report
2023-07-27
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20230727x8k.htm   iXBRL 8-K 73460
2 EX-10.1 ampe-20230727xex10d1.htm EX-10.1 121234
  Complete submission text file 0001558370-23-012601.txt   340015

Data Files

Seq Description Document Type Size
3 EX-101.SCH ampe-20230727.xsd EX-101.SCH 3369
4 EX-101.LAB ampe-20230727_lab.xml EX-101.LAB 15361
5 EX-101.PRE ampe-20230727_pre.xml EX-101.PRE 10376
7 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20230727x8k_htm.xml XML 4679
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 231128902
SIC: 2834 Pharmaceutical Preparations